Non-viral GMP manufacturing for engineered cells at clinical and commercial scale
Leif Anderson, Chris Abraham
AAV production and purification: key steps from design to GMP readiness
Goutham Ganjam, Florian Leseigneur, Emily Jackson-Holmes
Leveraging fluid dynamics characterization to accelerate cell therapy product development
Hamza Patel, Tom Heathman
To 1000L and beyond: streamlining AAV manufacturing with transfection complex stabilization
Leisha Kopp, Mason Bonitz
Navigating the transition from research to clinical-scale cell therapy manufacture
Steven Feldman, Johannes Fruehauf, Mary Ann Santos
A case study in faster, higher-quality pDNA manufacturing
Xiangming Gu, Lucas Smith